Catch up on highlights from the UK Biobank Scientific Conference 2025 which took place on 8 December 2025 at the QEII Conference Centre in London, UK.

An attendee at the UK Biobank Scientific Conference holds a microphone and asks a question to a panel

More than 900 people attended in person and over 1500 people registered to watch online from 50 countries, marking our biggest conference yet.

Researchers from across the world came together to hear from leading voices in academia, industry and policy. The programme spanned a rich array of sessions including focus on omics-driven discovery, the power of linked health records, the science of healthy ageing and expanding access through the UK Biobank Research Analysis Platform (UKB-RAP).

The discussions reflected the diversity and depth of research being conducted, and the growing potential of UK Biobank to accelerate breakthroughs across disciplines.

Watch back sessions

Take a look back at the conference sessions you may have missed.

Opening remarks

Speaker: Professor Rachel McKendry, Wellcome

Update from UK Biobank: Science, strategy and impact

Speaker: Professor Sir Rory Collins, UK Biobank

Long life, deep data: What can we discover about healthy ageing

Session Chair: Professor Cornelia Van Duijn, Oxford University
Presentations:
Professor Adam Hampshire, Imperial College London
Assistant Professor Junhao Wen, Columbia University
Dr Alexander Rau, Freiburg University
Professor Tony Wyss-Coray, Stanford Medicine
Panel discussion additional members:
Dr Julian Mutz, King’s College London
Dr Melissa Davis, Isomorphic Labs

UK Biobank’s impact

Speaker: Professor Melinda Mills, Oxford University
UK Biobank Impact Award Presentations
Speaker: Professor Sir Michael Ferguson

Read our news story on the Scientific Impact Award winner.

Towards precision medicine: Omics-driven discovery

Session Chair: Dr Melissa Miller, Pfizer
Presentations:
Dr Slave Petrovski, AstraZeneca
Professor Claudia Langenberg, QMUL
Dr Jeffrey Barrett, Nightingale Health
Professor Jonathan Mill, University of Exeter
Panel discussion additional members:
Dr Adam Laing, IMU Biosciences
Dr Aleksej Zelezniak, King’s College London and SynthBioLab

The UK Biobank Research Analysis Platform

Session Chair: Dr Will Salerno, Regeneron
Presentations:
Mark Conway, UK Biobank
Dr Lucy Burkitt-Gray, UK Biobank
Dr Lauren Carson, UK Biobank
Kira Levy, AWS
Panel discussion additional members:
Dr Jeff Keller, DNAnexus
Dr Mark Effingham, UK Biobank

Characterising health outcomes at scale

Session Chair: Professor Liam Smeeth, LSHTM
Presentations:
Dr Inesa Thomsen, UK Biobank
Dr Darren Treanor, N-PIC
Professor Martin Rutter, UK Biobank
Associate Professor Adam Lewandowski, UK Biobank
Panel discussion additional members:
Professor Joanne Edwards, Glasgow University
Professor Alastair Noyce, Queen Mary University of London

Closing remarks

Speaker: Tony Wood, GSK